Enzalutamide
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. (NCT02922218) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2016-06-01 |
Track Enzalutamide automatically
Every clearance here is in the API, with alerts when new ones post.